• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain

New FDA LDTs Guidance Offers Useful Summary, But Questions Remain

by Rachel Muenz | Jun 27, 2024 | News

Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details

Getting Started with the FDA’s New LDT Rule

Getting Started with the FDA’s New LDT Rule

by Michael Schubert, PhD | Jun 26, 2024 | Enforcement-lca, Essential, FDA-lca, Lab Industry Advisor, LDTs-lir, Top of the News-lir

Experts explain what the phase-in process will look like—and how labs can get ahead of the game.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
LDTs Around the World

LDTs Around the World

by Michael Schubert, PhD | Jun 4, 2024 | Enforcement-lca, Essential, Lab Industry Advisor, LDTs-lir, Legislation-lca, Top of the News-lir

Curious about how laboratory-developed tests are regulated in other countries? We compare in-house test guidance across six regions

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
3 Thoughts on the FDA’s Final LDTs Rule

3 Thoughts on the FDA’s Final LDTs Rule

by Rachel Muenz | May 14, 2024 | News

Regulatory expert Julie Ballard shares her first thoughts on the final rule for lab-developed tests and immediate steps for labs

Special Analysis: Two Key Legislative Initiatives Labs Should Know About

Special Analysis: Two Key Legislative Initiatives Labs Should Know About

by Scott Wallask | Apr 3, 2024 | Elite, Lab Industry Advisor, Legislation-lca

Though potential FDA LDTs regulation has drawn a lot of attention, other efforts could also have long-term effects on how labs do business.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com